Is non-alcoholic steatohepatitis caused by alcohol?

Article Sidebar

Archives of Community Medicine and Public Health volume6-issue1 articles
PDF HTML
Submitted: May 9, 2020
Published: May 26, 2020
DOI: 10.17352/2455-5479.000083

Main Article Content

Hubert E Blum*
Department of Medicine II, University of Freiburg, Clinic for Internal Medicine II, Hugstetter Strasse 55, D-79106 Freiburg, Germany

Downloads

Download data is not yet available.

Article Details

Blum, H. E. (2020). Is non-alcoholic steatohepatitis caused by alcohol?. Archives of Community Medicine and Public Health, 6(1), 081–083. https://doi.org/10.17352/2455-5479.000083
Commentaries

Copyright (c) 2020 Blum HE.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Rinella ME (2015) Nonalcoholic fatty liver disease: a systematic review. JAMA 313: 2263-2273. Link: https://bit.ly/3efRhUT

Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, et al. (2016) Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 64: 73-84. Link:https://bit.ly/2XukBAe

Younossi Z, Tacke F, Arrese M, Chander Sharma B, Mostafa I, et al. (2019) Global perspectives o nnonalcoholic fatty liver Disease and nonalcoholic steatohepatitis. Hepatology 69: 2672-2682. Link: https://bit.ly/2ZyHvt1

Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, et al. (2018) The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology 67: 328-357. Link: https://bit.ly/3bXptmR

Collaborators GBDD (2019) Health effects of dietary risks in 195 countries, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 393: 1958-1972. Link: https://bit.ly/2WZL2yH

Aberg F, Puukka P, Salomaa V, Mannisto S, Lundqvist A, et al. (2020) Risks of light and moderate alcohol use in fatty liver idisease: follow-up of population cohorts. Hepatology 71: 835-848. Link: https://bit.ly/3d7p02U

Boursier J, Mueller O, Barret M, Machado M, Fizanne L, et al. (2016) The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota. Hepatology 63: 764-775. Link: https://bit.ly/3goUS58

Caussy C, Hsu C, Lo MT, Liu A, Bettencourt R, et al. (2018) Link between gut-microbiome derived metabolite and shared gene-effects with hepatic steatosis and fibrosis in NAFLD. Hepatology 68: 918-932. Link:https://bit.ly/2Xmt8VW

Loomba R, Seguritan V, Li W, Long T, Klitgord N, et al. (2017) Gut microbiome-based metagenomic signature for non-invasive detection of advanced fibrosis in human nonalcoholic fatty liver Disease. Cell Metab 25: 1054-1062. e5. Link: https://bit.ly/3bZSUoh

Yuan J, Chen C, Cui J, Lu J, Yan C, et al. (2019) Fatty Liiver disease caused by high-alcohol-producing Klebsiella pneumoniae. Cell Metab 30: 675-688 e677. Link: https://bit.ly/2ZBtElE